Chargement en cours...
A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency
Non-invasive PET imaging of CXCR4 expression in cancer and inflammation as well as CXCR4-targeted radioligand therapy (RLT) have recently found their way into clinical research by the development of the theranostic agents [(68)Ga]PentixaFor (cyclo(D-Tyr(1)-D-[NMe]Orn(2)(AMBS-[(68)Ga]DOTA)-Arg(3)-Nal...
Enregistré dans:
| Publié dans: | Theranostics |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Ivyspring International Publisher
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7381729/ https://ncbi.nlm.nih.gov/pubmed/32724470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.45537 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|